Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis

Clinical Rheumatology

Volumn 30, Issue 4, 2011, Pages 529-535

  Kawasaki, Yukihiko ^a   Suyama, Kazuhide ^a   Hashimoto, Koichi ^a   Hosoya, Mitsuaki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

HSPN; Methylprednisolone pulse therapy; Mizoribine; Prognosis; Urokinase pulse therapy

Indexed keywords

METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; UROKINASE;

ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLAUCOMA; GROWTH RETARDATION; HENOCH SCHOENLEIN PURPURA NEPHRITIS; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LEUKOPENIA; MALE; NEPHRITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; SCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; PROGNOSIS; PROSPECTIVE STUDIES; PROTEINURIA; PULSE THERAPY, DRUG; PURPURA, SCHOENLEIN-HENOCH; RIBONUCLEOSIDES; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79954429973     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1572-6     Document Type: Article

References (25)

1. Habib R, Niaudet R, Levy M (1994) Schoenlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 427-523
2. Haycock GB (1998) The nephritis of Henoch-Schoenlein purpura. In: Cameron JS (ed) Oxford textbook of nephrology, 2nd edn. Oxford University Press, Oxford, pp 585-612
3. P Niaudet R Habib 1998 Methylprednisolone pulse therapy in the treatment of severe forms of Schoenlein-Henoch purpura nephritis Pediatr Nephrol 12 238 243 9630046 10.1007/s004670050446 1:STN:280:DyaK1c3ptF2qug%3D%3D (Pubitemid 28204133)
4. R Coppo G Mazzucco L Cagnoli A Lupo FP Schena 1997 Long-term prognosis of Henoch-Schoenlein nephritis in adults and children Nephrol Dial Transplant 12 2277 2283 9394311 10.1093/ndt/12.11.2277 1:STN:280:DyaK1c%2Fls1Wmsw%3D%3D (Pubitemid 27474607)
5. R Counahan MH Winterborn RH White JM Heaton SR Meadow NH Bluett H Swetschin JS Cameron C Chantler 1977 Prognosis of Henoch-Schoenlein nephritis in children Br Med J 2 11 14 871734 10.1136/bmj.2.6078.11 1:STN:280: DyaE2s3gt1GnsQ%3D%3D
6. K Iijima S Ito-Kariya H Nakamura N Yoshikawa 1998 Multiple combined therapy for severe Henoch-Schoenlein nephritis in children Pediatr Nephrol 12 244 248 9630047 10.1007/s004670050447 1:STN:280:DyaK1c3ptF2quw%3D%3D (Pubitemid 28204134)
7. BJ Foster C Bernaro KN Drummond AK Sharma 2000 Effective therapy for severe Henoch-Schoenlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study J Pediatr 136 370 375 10700695 10.1067/mpd.2000.103448 1:CAS:528:DC%2BD3cXit1KhtLY%3D (Pubitemid 30470961)
8. JT Flynn WE Smoyer TE Bunchman DB Kershaw AB Sedman 2001 Treatment of Henoch-Schoenlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide Am J Nephrol 21 128 133 11359020 10.1159/000046235 1:STN:280:DC%2BD3M3mslKjsA%3D%3D (Pubitemid 32453691)
9. A Oner K Tinaztepe O Erdogan 1995 The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis Pediatr Nephrol 9 6 10 7742225 10.1007/BF00858954 1:STN:280:DyaK2M3mtVOhsg%3D%3D
10. Y Kawasaki J Suzuki R Nozawa S Suzuki H Suzuki 2003 Efficacy of methylprednisolone and urokinase pulses therapy for severe Henoch-Schoenlein nephritis Pediatrics 111 785 789 12671112 10.1542/peds.111.4.785 (Pubitemid 36402902)
11. Y Kawasaki J Suzuki H Suzuki 2004 Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathologic study Nephrol Dial Transplant 19 858 864 15031341 10.1093/ndt/gfg617 1:CAS:528:DC%2BD2cXitl2lu78%3D (Pubitemid 38455656)
12. F Martin B Lauwerys C Lefèbvre JP Devogelaer FA Houssiau 1997 Side-effects of intravenous cyclophosphamide pulse therapy Lupus 6 244 247 10.1177/096120339700600307
13. YS Mizoribine 2002 Mode of action and effects in clinical use Pediatr Int 44 196 198 10.1046/j.1328-8067.2002.01536.x (Pubitemid 34225268)
14. K Yoshioka Y Ohashi T Sakai H Ito N Yoshikawa H Nakamura T Tanizawa H Wada S Maki 2000 A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome Kidney Int 58 317 324 10886577 10.1046/j.1523-1755.2000.00168.x 1:CAS:528:DC%2BD3cXltVyjtbY%3D (Pubitemid 30429877)
15. W Yumura S Suganuma K Uchida T Moriyama S Otsubo T Takei M Naito M Koike K Nitta H Nihei 2005 Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis Clin Nephrol 64 28 34 16047642 1:STN:280:DC%2BD2MzovFSksw%3D%3D (Pubitemid 40975062)
16. Y Kawasaki J Suzuki N Sakai S Etoh H Murai R Nozawa H Suzuki 2004 Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy Am J Nephrol 24 147 153 14726626 10.1159/000076243 1:CAS:528:DC%2BD2cXht1ahtL0%3D (Pubitemid 38250487)
17. Southwest Pediatric Nephrology Study Group 1985 A clinico-pathologic study of crescentic glomerulonephritis in 50 children: a report of the Southwest Pediatric Nephrology Study Group Kidney Int 27 450 458 10.1038/ki.1985.30
18. N Yoshikawa H Ito K Yoshiya C Nakahara S Yoshiara O Hasegawa S Matsuyama T Matsuo 1987 Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course Clin Nephrol 27 233 237 3594938 1:STN:280:DyaL2s3ksFSksA%3D%3D (Pubitemid 17068078)
19. JI Shinn JM Park YH Shin JH Kim JS Lee HJ Jeong 2005 Henoch-Schoenlein purpura nephritis with nephritic-range proteinuria: histological regression possibly associated with cyclosporine A and steroid treatment Scand J Rheumatol 34 392 395 10.1080/03009740510026544 (Pubitemid 41545914)
20. R Rezzani 2006 Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies Histol Histopathol 21 301 316 16372251 1:CAS:528:DC%2BD28Xpt1SqtA%3D%3D (Pubitemid 43033739)
21. K Tanabe T Tokumoto N Ishikawa A Kanematsu T Oshima M Harano M Inui T Yagisawa I Nakajima S Fuchinoue K Takahashi H Toma 1999 Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression Transplant Proc 83 2877 2879 10.1016/S0041-1345(99)00599-0 (Pubitemid 29525684)
22. K Sonda K Takahashi K Tanabe S Funchinoue Y Hayasaka H Kawaguchi S Teraoka H Toma K Ota 1996 Clinical pharmacokinetic study of mizoribine in renal transplantation patients Transplant Proc 28 3643 3648 8962403 1:CAS:528:DyaK2sXisFKjsg%3D%3D (Pubitemid 26415614)
23. H Tanaka K Tsugawa E Oki K Suzuki E Ito 2008 Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients Clin Rheumatol 27 85 89 17483980 10.1007/s10067-007-0635-9 (Pubitemid 350182682)
24. Y Kawasaki M Hosoya S Kobayashi S Ohara N Onishi A Takahashi M Isome H Suzuki 2005 Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome Nephrol Dial Transplant 20 2243 2247 16030039 10.1093/ndt/gfh996 1:CAS:528:DC%2BD2MXhtVWntL7E (Pubitemid 41510104)
25. Y Ohtomo S Fujinaga M Takada H Murakami S Akashi T Shimizu K Kaneko Y Yamashiro 2005 High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity Pediatr Nephrol 20 1744 1749 16133041 10.1007/s00467-005-2025-3 (Pubitemid 41722958)